Details for New Drug Application (NDA): 206211
✉ Email this page to a colleague
NDA 206211 describes POTASSIUM IODIDE, which is a drug marketed by Mission Pharmacal and Roxane and is included in two NDAs. It is available from one supplier. Additional details are available on the POTASSIUM IODIDE profile page.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
Summary for 206211
| Tradename: | POTASSIUM IODIDE |
| Applicant: | Mission Pharmacal |
| Ingredient: | potassium iodide |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 206211
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM IODIDE | potassium iodide | SOLUTION;ORAL | 206211 | ANDA | Mission Pharmacal Company | 0178-0314 | 0178-0314-30 | 1 BOTTLE, DROPPER in 1 CARTON (0178-0314-30) / 30 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION;ORAL | Strength | 65MG/ML | ||||
| Approval Date: | Mar 24, 2016 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
